©The Author(s) 2025.
World J Diabetes. Dec 15, 2025; 16(12): 112789
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.112789
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.112789
Table 3 General clinical data and leptin protein expression, n (%)
| Impaired glucose regulation | Type 2 diabetes mellitus | Normal glucose tolerance | |
| Impaired fasting glucose, impaired glucose tolerance | |||
| Number (male/female) | 44 (20/24), 50 (26/24) | 178 (88/90) | 120 (60/60) |
| Age (years) | 49.4 ± 6.2, 47.2 ± 6.3 | 47.5 ± 5.5 | 46.7 ± 7.4 |
| Body mass index (kg/m2) | 22.37 ± 2.66, 23.23 ± 3.52 | 22.99 ± 2.53 | 21.19 ± 3.42 |
| Leptin (μg/L) | 13.79 ± 3.32, 12.62 ± 4.81 | 16.94 ± 4.19a | 11.33 ± 3.10 |
| Hypertension (%) | 12 (27.3), 17 (34) | 41 (23.1) | 26 (21.7) |
| Smoking (%) | 9 (20.5), 12 (26) | 44 (24.7) | 27 (22.5) |
- Citation: Sun SQ, Liang SZ, Huang Q, Sun JZ. Methylation status of leptin gene promoter in relatively lean Chinese adults with prediabetes and type 2 diabetes mellitus. World J Diabetes 2025; 16(12): 112789
- URL: https://www.wjgnet.com/1948-9358/full/v16/i12/112789.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i12.112789